Update-2 Another Roller Coaster Week helped by AMZN earnings and jobs report.. Healthcare SPDR Sector (XLV) up 1.39% for week, (4.19%) YTD; IBB up 2.08% for week, (14.4%) YTD;  XBI up 2.49% for week, (18.9%)  YTD.

Large cap healthcare stock leaders over 52 weeks: UNH, ABBV, GSK, VRTX. Sector leaders for the week: energy, discretionary, financials, Russell 2000, healthcare. Medtech looks to future after Omicron with US Medical Devices (IHI) up 3.56% for the week but down 9% YTD. Watch ISRG and MDT, ABT up 3.48% for week.

Teetering off the bottom in biotech but more tradeable for smaller caps. Large cap biopharma provides value plus dividends in a volatile market. We will summarize performance next week.

Update-1 2/3…Top Pick: Abbvie beats stock up 1.88% to $141 handle. EPS $12.70 up 20.3%, REVS $56.197 up 22.7%.

Merck (MRK) earnings and revenues beat COVID antiviral sales soar to $952M, guides to $5-6B but stock is down over 3%.

Roche (RHHBY) down over 2% of EPS miss revenue beat but warned that COVID related Dx and Rx could decline.

=======

Healthcare Portfolio Performance January 2022

  • January sell-off hits (normally defensive) healthcare stocks.
  • Biotech stocks continue down but large cap biopharmas do well.
  • Investors rotate into value and energy,

The worst month since 2009 ended on a positive note as Friday the 28th of January through today February 1 showed a tradeable bottom.. The current rally shows three days of gains particularly with the NASDAQ-100 (QQQ) off the bottom of $340 to the $365 level today.

Just about everything was down in January except commodity stocks, crude oil and energy (XLE) which rose another 5% last week. Even our core holding United Health(UNH) was down 5.89% for the month after running up 43.84% in 2021. 2021 UNH Revs were up 12% YoY. Update- UNH up 5.9% over past five days  to $489. The SPDR select healthcare Funds (XLV) was a down 6.86%

Biotech ETFs were hit hard with the XBI down 16.55% for the month and the larger cap weighted IBB down 13.6% for January. Note that in our posts throughout 2021 we were bullish on large cap biopharma particularly ABBV BMY and VRTX. We were also bearish on small cap Biopharmaceuticals as investor sentiment shifted to “risk off” and more fundamental analysis of companies and financial strength. This trend is also evident in the weakness of the Russell 2000 (IWM) which correlates to small cap biotech strength. For traders the XBI rocks already up 10 pts from Friday’s low. to $95!

The US Medical Device (IHI) ETF was down 10% reflecting the impact of Omicron COVID headwinds and labor shortages inhibiting elective surgical procedures.Similarly the Fidelity Select Medical Technology Fund (FSMEX) was down over 14%.

MODEL Healthcare Portfolio as of 1/31/22

2020 2020 2020 2021 2022
Ticker Price Wgt Price Price 1 year Price Month
10/25 % 12/31 % Perf 12/31/21 % Perf 1/31/22 %Perf
Month
IBB 136 25 151.5 25.7 152.62 0.75 131.86 -13.6
IWM 163 10 196.4 18.3 222.45 13.46 201.24 -9.53
MRK 80 5 81.77 -10 76.64 -1.81 81.48 6.32 or PFE
UNH 330 15 350.7 27.19 502 43.84 472.57 -5.89
XBI 117 5 140.8 48 111.96 -20.5 93.43 -16.55
XLV 108 25 113.4 14.71 140.89 24.73 131.23 -6.86
PRHSX 99.65 104 5.29 91.19 -12.38 ytd
IHI 50 15 54.83 65.85 21.4 59 -10.4
COMP
ARKG 93.26 61.24 -33 49.7 -18.84
FBIOX 25.18 19.35 -23 16.23 -16.12 ytd
FSMEX 76.15 83.18 14.71 71.4 -14.16 ytd
DIA 310 363.3 19.31 351 -3.37
SPY 379 475 27.7 449.91 -5.27
QQQ 315 397.85 28 363.05 -8.75

Pin It on Pinterest